This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its...
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source...
Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced...
New data released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of employment-related drug testing services,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the...
Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced...
Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
MedPlus®, the healthcare information technology subsidiary of Quest Diagnostics® Incorporated (NYSE: DGX), today announced the release of ChartMaxx®...
Maggie Gunter, PhD, president of the New Mexico Health Information Collaborative (NMHIC), announced today that the organization has been...
MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced today that it has been...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the...
The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease...
DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its...
Methodist Hospital of Arcadia, California, has launched an integrated deployment of innovative health care information technology (HIT) solutions...
Vermillion, Inc (OTC: VRMLQ.PK) today announced that Eric Fung, M.D., Ph.D., has rejoined the company to become its Chief Science Officer. This...
Quest Diagnostics (NYSE: DGX) today announced plans to make it easy for every physician in the United States to quickly embrace digital healthcare...
The U.S. Food and Drug Administration (FDA) today cleared the OVA1™ Test, the first blood test that, prior to surgery, can...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that it...
Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated (NYSE: DGX), today announced that its Influenza...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the...
MedPlus, the healthcare information technology subsidiary of Quest Diagnostics...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its...
National Business Group on Health Recognizes HealthyQuest Program for Fifth Consecutive Year MADISON, N.J., June 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the...
Agreement with Medical Automation Systems, Inc. Will Add RALS®-Plus Module to Company's Hemoglobin and Glucose Handheld Devices MADISON, N.J., June 22 /PRNewswire-FirstCall/ -- HemoCue Inc., the...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the final...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the...
Faster reporting aids physicians in identifying HIV mutations that can inhibit effectiveness of newest class of antiretroviral therapy MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest...
A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore™ liver fibrosis...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
Health Information Exchange for Medicaid Beneficiaries, Powered by MedPlus Centergy™ Solutions, will Connect Physicians, Hospitals and Clinics to Accelerate Access to Patient Information and...
Quest4Health.com Lauded in Healthcare Category for 'Visionary Application of Information Technology to Promote Positive Social and Economic Progress' MADISON, N.J., June 3 /PRNewswire-FirstCall/...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that, as...
Agreement to Distribute MEC HbA1c Test To Provide Physicians in U.S. and Europe With Fast, Accurate Near-Patient Test for Diabetes Monitoring MADISON, N.J., June 2 /PRNewswire-FirstCall/ --...
EGFR Pathway Test analyzes in sequential reflex fashion more mutations potentially inhibiting anti-EGFR therapy response in metastatic colorectal cancer patients MADISON, N.J., June 1...
Quest Diagnostics scientists will present results of three studies revealing the effect of genomic abnormalities on the diagnosis and treatment of...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
Quest Diagnostics Incorporated (NYSE: DGX) announced today that it will enable patients and their physicians to share diagnostic laboratory test...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its...